Single Intravenous Dose of Oritavancin for Treatment of Acute Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: Summary of Safety Analysis from the Phase 3 SOLO Studies
2018
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
30
References
0
Citations
NaN
KQI